Calgene Inc. (NASDAQ:CGNE) filed with the SEC Monday for apublic offering of two million shares of common stock plus anover-allotment option for an additional 300,000 shares. Thecompany hopes to raise approximately $32 million, primarily tofinance commercialization of the company's geneticallyengineered Flavr Savr tomato.
Monday's filing represents Calgene's fifth round of publicfinancing. The Davis, Calif. company has raised roughly $130million in offerings since 1987. The offering will be managed inthe U.S. by PaineWebber Inc. and Montgomery Securities.Calgene's stock closed Monday at $15.75, down $1.25 a share.
(c) 1997 American Health Consultants. All rights reserved.